Kao (4452) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
8 Jan, 2026Executive summary
Fiscal 2025 is a foundation-building year for global growth, with a focus on profitability in stable earnings areas and reinvestment in growth segments.
Achieved Q1 FY2025 sales and profits above plan, with operating margin up 2.0 points year-over-year, driven by volume growth and improved earning power.
Net sales rose 6.6% year-over-year to 389.9 billion yen, with like-for-like growth of 6.0% driven by 1.6% volume and 4.4% price increases.
Operating income increased 41.9% to 31.2 billion yen, and net income attributable to owners of the parent grew 38.7% to 22.9 billion yen.
Growth was supported by strong performance in Japan, price adjustments, and high-value product launches, despite global economic uncertainty and rising raw material costs.
Financial highlights
Net sales rose 6.6% year-over-year to 389.9 billion yen; like-for-like growth was 6.0%.
Gross profit increased 8.0% to 148.0 billion yen; gross margin improved 0.5 points to 38.0%.
Operating income reached 31.2 billion yen, up 41.9% year-over-year; operating margin improved to 8.0%.
Net income attributable to owners was 22.8 billion yen, up 38.7% year-over-year; EPS up 38.9% to 49.19 yen.
EBITDA increased 19.6% to 52.7 billion yen.
Outlook and guidance
Full-year 2025 net sales forecast at 1,670 billion yen (+2.6% YoY), operating income at 160 billion yen (+9.1%), and net income attributable to owners at 116 billion yen (+7.9%).
Full-year earnings forecast for fiscal 2025 is maintained despite U.S. tariff risks and global uncertainties.
Impact of tariffs on operating income expected to be limited to 2.0 billion yen at most; mitigation measures in place.
Raw material prices are expected to remain high, but offsetting measures and price adjustments are planned.
K27 mid-term targets include ROIC of 11%+ and operating income of 211.7 billion yen by FY2027.
Latest events from Kao
- Profits and sales rose, with a share split and higher dividends planned for FY2026.4452
Q4 20256 Feb 2026 - H1 operating income up 68%, full-year outlook raised, but China remains a challenge.4452
Q2 20242 Feb 2026 - Profit and margin growth surged on reforms and premiumization, offsetting China cosmetics weakness.4452
Q3 202416 Jan 2026 - Profit and ROIC surged on reforms; 2025 targets further growth and global expansion.4452
Q4 20248 Jan 2026 - Profitability and margins rose, driven by high-value products and Cosmetics recovery.4452
Q3 202516 Dec 2025 - Upward forecast revision and major share buyback follow strong H1 results and improved profitability.4452
Q2 202523 Nov 2025